{"markup":"\u003C?xml version=\u00221.0\u0022 encoding=\u0022UTF-8\u0022 ?\u003E\n    \u003Chtml version=\u0022HTML+RDFa+MathML 1.1\u0022\n    xmlns:content=\u0022http:\/\/purl.org\/rss\/1.0\/modules\/content\/\u0022\n    xmlns:dc=\u0022http:\/\/purl.org\/dc\/terms\/\u0022\n    xmlns:foaf=\u0022http:\/\/xmlns.com\/foaf\/0.1\/\u0022\n    xmlns:og=\u0022http:\/\/ogp.me\/ns#\u0022\n    xmlns:rdfs=\u0022http:\/\/www.w3.org\/2000\/01\/rdf-schema#\u0022\n    xmlns:sioc=\u0022http:\/\/rdfs.org\/sioc\/ns#\u0022\n    xmlns:sioct=\u0022http:\/\/rdfs.org\/sioc\/types#\u0022\n    xmlns:skos=\u0022http:\/\/www.w3.org\/2004\/02\/skos\/core#\u0022\n    xmlns:xsd=\u0022http:\/\/www.w3.org\/2001\/XMLSchema#\u0022\n    xmlns:mml=\u0022http:\/\/www.w3.org\/1998\/Math\/MathML\u0022\u003E\n  \u003Chead\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_YjAJQgxDlFX6S-O02jj9jCrVbrwlY3CGgCg1FzPlvBs.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\nif(typeof window.MathJax === \u0022undefined\u0022) window.MathJax = { menuSettings: { zoom: \u0022Click\u0022 } };\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_waP91NpgGpectm_6Y2XDEauLJ8WCSCBKmmA87unpp2E.js\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.googletagmanager.com\/gtag\/js?id=G-0K57TCX5BY\u0022\u003E\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\nwindow.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments)};gtag(\u0022js\u0022, new Date());gtag(\u0022set\u0022, \u0022developer_id.dMDhkMT\u0022, true);gtag(\u0022config\u0022, \u0022G-0K57TCX5BY\u0022, {\u0022groups\u0022:\u0022default\u0022,\u0022anonymize_ip\u0022:true});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Cscript type=\u0022text\/javascript\u0022\u003E\n\u003C!--\/\/--\u003E\u003C![CDATA[\/\/\u003E\u003C!--\njQuery.extend(Drupal.settings, {\u0022basePath\u0022:\u0022\\\/\u0022,\u0022pathPrefix\u0022:\u0022\u0022,\u0022highwire\u0022:{\u0022ac\u0022:{\u0022medrxiv;2023.09.24.23296009v1\u0022:{\u0022access\u0022:{\u0022full\u0022:true},\u0022pisa_id\u0022:\u0022medrxiv;2023.09.24.23296009v1\u0022,\u0022apath\u0022:\u0022\u0022,\u0022jcode\u0022:\u0022medrxiv\u0022}},\u0022processed\u0022:[\u0022highwire_math\u0022],\u0022markup\u0022:[{\u0022requested\u0022:\u0022full-text\u0022,\u0022variant\u0022:\u0022full-text\u0022,\u0022view\u0022:\u0022full\u0022,\u0022pisa\u0022:\u0022medrxiv;2023.09.24.23296009v1\u0022}]},\u0022instances\u0022:\u0022{\\u0022highwire_abstract_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:20,\\u0022height\\u0022:20,\\u0022border\\u0022:1,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-abstract-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022right center\\u0022,\\u0022my\\u0022:\\u0022left center\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022shift\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter click \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}},\\u0022highwire_author_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:15,\\u0022height\\u0022:15,\\u0022border\\u0022:1,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-author-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022top center\\u0022,\\u0022my\\u0022:\\u0022bottom center\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}},\\u0022highwire_reflinks_tooltip\\u0022:{\\u0022content\\u0022:{\\u0022text\\u0022:\\u0022\\u0022},\\u0022style\\u0022:{\\u0022tip\\u0022:{\\u0022width\\u0022:15,\\u0022height\\u0022:15,\\u0022border\\u0022:1,\\u0022mimic\\u0022:\\u0022top center\\u0022,\\u0022offset\\u0022:0,\\u0022corner\\u0022:true},\\u0022classes\\u0022:\\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\\u0022,\\u0022classes_custom\\u0022:\\u0022hw-tooltip hw-ref-link-tooltip\\u0022},\\u0022position\\u0022:{\\u0022at\\u0022:\\u0022bottom left\\u0022,\\u0022my\\u0022:\\u0022top left\\u0022,\\u0022viewport\\u0022:true,\\u0022adjust\\u0022:{\\u0022method\\u0022:\\u0022flip\\u0022}},\\u0022show\\u0022:{\\u0022event\\u0022:\\u0022mouseenter \\u0022,\\u0022solo\\u0022:true},\\u0022hide\\u0022:{\\u0022event\\u0022:\\u0022mouseleave \\u0022,\\u0022fixed\\u0022:1,\\u0022delay\\u0022:\\u0022100\\u0022}}}\u0022,\u0022qtipDebug\u0022:\u0022{\\u0022leaveElement\\u0022:0}\u0022,\u0022googleanalytics\u0022:{\u0022account\u0022:[\u0022G-0K57TCX5BY\u0022],\u0022trackOutbound\u0022:1,\u0022trackMailto\u0022:1,\u0022trackDownload\u0022:1,\u0022trackDownloadExtensions\u0022:\u00227z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip\u0022,\u0022trackColorbox\u0022:1},\u0022ajaxPageState\u0022:{\u0022js\u0022:{\u0022\\\/\\\/cdn.jsdelivr.net\\\/qtip2\\\/2.2.1\\\/jquery.qtip.min.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_article_reference_popup.js\u0022:1,\u0022sites\\\/all\\\/modules\\\/highwire\\\/highwire\\\/plugins\\\/highwire_markup_process\\\/js\\\/highwire_at_symbol.js\u0022:1,\u00220\u0022:1,\u0022sites\\\/all\\\/modules\\\/contrib\\\/google_analytics\\\/googleanalytics.js\u0022:1,\u0022https:\\\/\\\/www.googletagmanager.com\\\/gtag\\\/js?id=G-0K57TCX5BY\u0022:1,\u00221\u0022:1}}});\n\/\/--\u003E\u003C!]]\u003E\n\u003C\/script\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/advagg_css\/css__dn-cpI1YtkU_iLHgA5WhlkxgYWyat_IxjF_B-WSYrpE__a9hIbt0eaZ7d5nhwnm2weG8R_2eXK4EvoOx9dOxouHE__QrrGUc7CpljPR5Aph-ukPbcwtK4AWrHGwCEXJ_k1V_c.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink type=\u0022text\/css\u0022 rel=\u0022stylesheet\u0022 href=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/advagg_css\/css__HGACIFBlu2o05y3afvqlt5wrE_5Dn6MXsexfuEpeIwg__t4SOPxucAPoV3Os7g8dXqyMB1HRXQridRJ82X7nE33E__QrrGUc7CpljPR5Aph-ukPbcwtK4AWrHGwCEXJ_k1V_c.css\u0022 media=\u0022all\u0022 \/\u003E\n\u003Clink rel=\u0027stylesheet\u0027 type=\u0027text\/css\u0027 href=\u0027\/sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css\u0027 \/\u003E\u003C\/head\u003E\u003Cbody\u003E\u003Cdiv class=\u0022panels-ajax-tab-panel panels-ajax-tab-panel-article-tab-full-text\u0022\u003E\u003Cdiv class=\u0022panel-display panel-1col clearfix\u0022 \u003E\n  \u003Cdiv class=\u0022panel-panel panel-col\u0022\u003E\n    \u003Cdiv\u003E\u003Cdiv class=\u0022panel-pane pane-highwire-markup\u0022 \u003E\n  \n      \n  \n  \u003Cdiv class=\u0022pane-content\u0022\u003E\n    \u003Cdiv class=\u0022highwire-markup\u0022\u003E\u003Cdiv xmlns=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022 data-highwire-cite-ref-tooltip-instance=\u0022highwire_reflinks_tooltip\u0022 class=\u0022content-block-markup\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cdiv class=\u0022article fulltext-view \u0022\u003E\u003Cspan class=\u0022highwire-journal-article-marker-start\u0022\u003E\u003C\/span\u003E\u003Cdiv class=\u0022section abstract\u0022 id=\u0022abstract-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EAbstract\u003C\/h2\u003E\u003Cp id=\u0022p-3\u0022\u003ERare kidney diseases are not well characterised, despite making a significant contribution to the burden of kidney disease globally. The National Registry of Rare Kidney Diseases (RaDaR) collects longitudinal disease and treatment related data from people living with rare kidney diseases across the UK, and is the largest rare kidney disease registry in the world. We present the clinical demographics and renal function of 25,880 prevalent patients and evaluate for any potential recruitment bias to RaDaR.\u003C\/p\u003E\u003Cp id=\u0022p-4\u0022\u003ERaDaR recruits patients from 108 UK hospitals and is linked with the UK Renal Registry (UKRR, with which all UK patients receiving Kidney Replacement Therapy (KRT) are registered). To assess for recruitment bias to RaDaR we performed three comparisons of ethnicity and socioeconomic status: 1) All prevalent RaDaR patients receiving KRT were compared with patients with eligible rare disease diagnoses receiving KRT in the UKRR 2) Patients recruited to RaDaR and all eligible unrecruited patients at two renal centres were compared 3) The age-stratified ethnicity distribution RaDaR patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) was compared with the English Census.\u003C\/p\u003E\u003Cp id=\u0022p-5\u0022\u003EWe observed over-representation of individuals reporting South Asian ethnicity in some rare diseases (most markedly Cystinosis and Primary Hyperoxaluria). We found no evidence of systematic bias in recruitment to RaDaR in terms of ethnicity or social deprivation. Predominant rare kidney diseases in adults (\u226518 years) were ADPKD (29.2%), Vasculitis (15.8%) and IgA nephropathy (15.7%), compared to Idiopathic nephrotic syndrome (43.6%), Vasculitis (10.8%) and Alport Syndrome (5.9%) in children (\u0026lt;18 years). Compared with either adults recruited to RaDaR or the general UK population, children recruited to RaDaR were more likely to be of Asian ethnicity and live in more socially deprived areas.\u003C\/p\u003E\u003Cdiv id=\u0022sec-1\u0022 class=\u0022subsection\u0022\u003E\u003Cp id=\u0022p-6\u0022\u003E\u003Cstrong\u003ELay Summary\u003C\/strong\u003E Rare kidney diseases make a significant contribution to the number of people living with kidney disease globally: \u0026gt;25% of adults and \u0026gt;50% of children with kidney failure have a rare disease. However, there is a lack of high-quality published data on how these conditions present, and in which patient groups. Patients often face delays in diagnosis and lack of reliable information on their condition once diagnosed. The UK National Registry of Rare Kidney Diseases (RaDaR) was formed in 2010 to address this knowledge gap. It collects long-term data for UK patients with rare kidney conditions, and is the largest rare kidney disease registry in the world. Here, we present information about 25,880 adults and children recruited to RaDaR, including ethnicity, socioeconomic status, and kidney function, and investigate whether there is any bias in recruitment to RaDaR. To our knowledge, this is the largest epidemiological description of rare kidney diseases worldwide.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022kwd-group Author\u0022\u003E\u003Cli class=\u0022kwd\u0022\u003ERare Kidney Diseases\u003C\/li\u003E\u003Cli class=\u0022kwd\u0022\u003ERare kidney disease registry\u003C\/li\u003E\u003Cli class=\u0022kwd\u0022\u003EEthnicity\u003C\/li\u003E\u003Cli class=\u0022kwd\u0022\u003ESocial deprivation\u003C\/li\u003E\u003C\/ul\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-2\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EIntroduction\u003C\/h2\u003E\u003Cp id=\u0022p-19\u0022\u003EA rare disease is defined in Europe as a condition affecting less than 1 in 2000 people \u003Csup\u003E\u003Ca id=\u0022xref-ref-1-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-1\u0022\u003E1\u003C\/a\u003E\u003C\/sup\u003E, and in the USA as affecting fewer than 200,000 individuals in the country\u003Csup\u003E\u003Ca id=\u0022xref-ref-2-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-2\u0022\u003E2\u003C\/a\u003E\u003C\/sup\u003E. Rare kidney diseases make a significant contribution to the burden of kidney disease in the UK and globally: at least 25% of adults and over 50% of children receiving kidney replacement therapy (KRT) have a rare disease\u003Csup\u003E\u003Ca id=\u0022xref-ref-3-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-3\u0022\u003E3\u003C\/a\u003E\u003C\/sup\u003E with \u2018glomerulonephritis\u2019 the single commonest category of Primary Renal Disease among UK patients receiving KRT\u003Csup\u003E\u003Ca id=\u0022xref-ref-4-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-4\u0022\u003E4\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-20\u0022\u003ESmall patient numbers can result in challenges in clinical management and research in rare diseases: lack of clinical experience, even in large academic centres can lead to delays or errors in diagnosis and treatment of rare diseases; and low disease incidence alongside underdiagnosis can make identification of patients eligible for clinical trials and observational studies challenging. Adequate patient numbers for meaningful analysis may only be achieved through collaboration between multiple large renal centres, associated with considerable administrative burden\u003Csup\u003E\u003Ca id=\u0022xref-ref-5-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-5\u0022\u003E5\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-21\u0022\u003EKidney disorders can cause multi-system dysfunction and may require complex multidisciplinary care at different specialist centres. Advances in KRT have led to people with rare kidney disorders surviving for decades with Kidney Failure (KF)\u003Csup\u003E\u003Ca id=\u0022xref-ref-1-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-1\u0022\u003E1\u003C\/a\u003E\u003C\/sup\u003E so the requirement for long-term follow-up data is paramount. For children with rare kidney diseases, life-time follow-up across different specialist paediatric and adult healthcare centres across different regions may be needed, leading to fragmentation of records across multiple databases, systems, and health care providers which is challenging to access for research. Rare kidney disorders are therefore frequently poorly characterized, lacking published data on the determinants, distribution, and long-term outcomes of these diseases.\u003C\/p\u003E\u003Cp id=\u0022p-22\u0022\u003EThe National Rare Kidney Disease Registry (RaDaR), set-up in 2010 by the UK Kidney Association (UKKA) with funding from the Medical Research Council, Kidney Care UK and Kidney Research UK, was designed to address these challenges by collecting longitudinal data for adults and children with rare kidney diseases in the UK. Uniquely embedded with the publicly funded National Health Service (NHS) to which all UK residents have free access, RaDaR is hosted by the UK Renal Registry (UKRR) and has UK-wide ethical approval as a research registry, enabling collection of retrospective and prospective data for patients across multiple healthcare systems and regions. Aims of RaDaR include to i) better understand the natural history of rare kidney diseases; ii) assess long-term effects of therapies; iii) identify cohorts eligible for clinical research; iv) provide infrastructure for individual rare disease studies and sub-registries.\u003C\/p\u003E\u003Cp id=\u0022p-23\u0022\u003ERaDaR is the largest rare kidney disease registry worldwide. Here we describe the design and set-up of RaDaR, and present cross-sectional analyses of 25,880 prevalent patients and minimum point prevalence estimates for 21 rare kidney diseases in the UK.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-3\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EMaterials and methods\u003C\/h2\u003E\u003Cdiv id=\u0022sec-4\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EDesign and structure of RaDaR\u003C\/h3\u003E\u003Cp id=\u0022p-24\u0022\u003ERecruitment and data transfer are summarised in \u003Ca id=\u0022xref-fig-1-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F1\u0022\u003EFigure 1\u003C\/a\u003E. All participants sign a paper or e-consent form, consenting to access and analysis of retrospective and prospective clinical data, and in most cases to sharing of their data from other databases, studies and registries, and to be contacted for future research studies they may be eligible for. All data are held centrally in a Structured Query Language database at the UKRR. NIHR (National Institute for Health and Care Research) infrastructure and research nurse supports NHS sites to manually enter a minimal set of mandatory fields at time of recruitment to RaDaR; this infrastructure has also supported other national research programmes such as the RECOVERY\u003Csup\u003E\u003Ca id=\u0022xref-ref-6-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-6\u0022\u003E6\u003C\/a\u003E\u003C\/sup\u003E trial. Manual data entry is automatically checked using defined ranges to identify implausible data.\u003C\/p\u003E\u003Cdiv id=\u0022F1\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F1.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Design, recruitment, and data flow to RaDaR\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-2128557798\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;Design, recruitment, and data flow to RaDaR\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 1:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F1.medium.gif\u0022 width=\u0022440\u0022 height=\u0022264\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 1:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F1.medium.gif\u0022 width=\u0022440\u0022 height=\u0022264\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F1.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 1:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F1.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022 xmlns:xhtml=\u0022http:\/\/www.w3.org\/1999\/xhtml\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 1:\u003C\/span\u003E \u003Cp id=\u0022p-25\u0022 class=\u0022first-child\u0022\u003EDesign, recruitment, and data flow to RaDaR\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-26\u0022\u003EData on all patients recruited to RaDaR were extracted on July 25\u003Csup\u003Eth\u003C\/sup\u003E 2022.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-5\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ERare disease groups (RDGS)\u003C\/h3\u003E\u003Cp id=\u0022p-27\u0022\u003EParticipants are recruited into 29 Rare Disease Groups (RDGs) which may comprise a single disease entity or groups of renal diagnoses. Full eligibility criteria for each RDG are available online at \u003Ca href=\u0022https:\/\/ukkidney.org\/sites\/renal.org\/files\/radar\/Inclusion-Exclusion_april_2021_v22.pdf\u0022\u003Ehttps:\/\/ukkidney.org\/sites\/renal.org\/files\/radar\/Inclusion-Exclusion_april_2021_v22.pdf\u003C\/a\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-28\u0022\u003EData for RDGs with \u0026gt; 85 patients recruited are presented: Autosomal Dominant Polycystic Kidney Disease (ADPKD), Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD), Atypical Haemolytic Uraemic Syndrome (aHUS), Alport Syndrome (AS), Autosomal Recessive Polycystic Kidney Disease and Nephronophthisis (ARPKD\/NPHP), Hepatocyte Nuclear Factor-1 Beta (\u003Cem\u003EHNF1B\u003C\/em\u003E) mutations, IgA nephropathy, Idiopathic Nephrotic Syndrome (INS), Membranous Nephropathy, Monoclonal Gammopathy of Renal Significance (MGRS), Membranoproliferative Glomerulonephritis and C3 Glomerulopathy (MPGN\/C3GN), Pregnancy, Inherited Renal Cancers, Retroperitoneal Fibrosis, Shiga Toxin\/verotoxin-producing Escherichia Coli associated Haemolytic Uraemic Syndrome (STEC-HUS), Tuberous Sclerosis Complex (TSC), Vasculitis, Cystinosis, Cystinuria, Primary Hyperoxaluria and Tubulopathies.\u003C\/p\u003E\u003Cp id=\u0022p-29\u0022\u003EData from individuals with AS with a clinical diagnosis of X-linked AS or Thin Basement Membrane Nephropathy (TBMN) are reported with results for males and females with X-Linked AS, and individuals with TBMN presented separately. Patients with two \u003Cem\u003ECOL4A3\u003C\/em\u003E or \u003Cem\u003ECOL4A4\u003C\/em\u003E pathogenic variants (autosomal recessive AS) have been excluded due to small sample size.\u003C\/p\u003E\u003Cp id=\u0022p-30\u0022\u003EResults for the Vasculitis RDG are presented stratified into ANCA-associated vasculitis, Anti-GBM disease and Other Vasculitides (including large vessel and IgA vasculitis). The INS cohort is presented stratified into patients with a diagnosis of either Steroid Sensitive Nephrotic Syndrome or Minimal Change Disease (SSNS\/MCD); Steroid Resistant Nephrotic Syndrome, Congenital Nephrotic Syndrome or Focal Segmental Glomerulosclerosis (SRNS\/FSGS); or INS-unspecified (patients in the INS cohort without a confirmed diagnosis of SSNS, MCD, SRNS, Congenital Nephrotic syndrome or FSGS).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-6\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EData linkage\u003C\/h3\u003E\u003Cp id=\u0022p-31\u0022\u003ERaDaR is linked with the UKRR for data on KRT initiation and death, which receives data from NHS Blood and Transplant for transplantation events. Rates of KRT data received from the UKRR are correct as of 1st January 2022. Routine laboratory data are extracted via automated feed either directly from renal unit IT systems or via the UK Renal Data Collaboration (UKRDC).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-7\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EDemographic data\u003C\/h3\u003E\u003Cp id=\u0022p-32\u0022\u003ESelf-reported patient ethnicity (Office of National Statistics (ONS) census categories\u003Csup\u003E\u003Ca id=\u0022xref-ref-7-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-7\u0022\u003E7\u003C\/a\u003E\u003C\/sup\u003E) is entered manually by a research nurse at time of recruitment or populated from existing clinical data provided by the UKRDC. Sex is recorded according to UKRDC record. Postcodes (zipcodes) were used to derive Index of Multiple Deprivation (IMD) scores as an area level measure of socioeconomic status (SES). IMD is a measure of relative deprivation for small areas within a country from most deprived to least deprived (1 = most deprived). Each country in the UK (England\u003Csup\u003E\u003Ca id=\u0022xref-ref-8-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-8\u0022\u003E8\u003C\/a\u003E\u003C\/sup\u003E, Wales\u003Csup\u003E\u003Ca id=\u0022xref-ref-9-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-9\u0022\u003E9\u003C\/a\u003E\u003C\/sup\u003E, Scotland\u003Csup\u003E\u003Ca id=\u0022xref-ref-10-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-10\u0022\u003E10\u003C\/a\u003E\u003C\/sup\u003E and Northern Ireland\u003Csup\u003E\u003Ca id=\u0022xref-ref-11-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-11\u0022\u003E11\u003C\/a\u003E\u003C\/sup\u003E) has an IMD. These can then be categorised into country-specific quintiles within each country (Quintile 1 = most deprived, Quintile 5 = least deprived).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-8\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ERenal function\u003C\/h3\u003E\u003Cp id=\u0022p-33\u0022\u003EFor patients not receiving KRT, eGFR was calculated using CKD-EPI Cr equation without race adjustment (2009)\u003Csup\u003E\u003Ca id=\u0022xref-ref-12-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-12\u0022\u003E12\u003C\/a\u003E\u003C\/sup\u003E or Schwartz equation for patients \u2264 16 years old.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-9\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EMissing data\u003C\/h3\u003E\u003Cp id=\u0022p-34\u0022\u003EAvailable data are presented for each variable and patterns for missing data explored and proportions presented in Supplementary Tables 1-3.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-10\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ESmall number suppression\u003C\/h3\u003E\u003Cp id=\u0022p-35\u0022\u003EWhere a risk of re-identification of participants has been identified, groups with small numbers have been aggregated into larger groups and tabulated data has been structured not to report fewer than five participants per cell where possible. Where cells contained \u22646 counts, this cell has been suppressed. To avoid possibility of calculation of suppressed counts, corresponding cells are rounded to the nearest 5, in accordance with NHS Digital guidance\u003Csup\u003E\u003Ca id=\u0022xref-ref-13-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-13\u0022\u003E13\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-11\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EMinimum point prevalence estimates\u003C\/h3\u003E\u003Cp id=\u0022p-36\u0022\u003EUK wide RaDaR point prevalence estimates were calculated using patient numbers for each RDG, and stratified by sex, using ONS UK population data\u003Csup\u003E\u003Ca id=\u0022xref-ref-14-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-14\u0022\u003E14\u003C\/a\u003E\u003C\/sup\u003E and are presented per 100,000 population. Prevalence estimates were also calculated for each RDG for each UK Health Board, and maximum estimated rate for each RDG are presented. Due to the nature of recruitment to RaDaR, which requires informed consent from participants, these estimated UK-wide rates will under-estimate the true rate of rare kidney diseases but could be interpreted as minimum possible rates.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-12\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EStatistical analyses\u003C\/h3\u003E\u003Cp id=\u0022p-37\u0022\u003EBaseline characteristics are presented as frequencies (%) for categorical data and medians and IQR for non-normally distributed continuous data. Chi-square or Fishers exact tests were used to compare categorical variables. Statistical analyses were performed using STATA Release 17 (StataCorp LLC) or SAS version 9.4 (SAS Institute Inc).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-13\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ERecruitment comparisons\u003C\/h3\u003E\u003Cp id=\u0022p-38\u0022\u003EPrimary renal diagnosis (PRD) is recorded in the UKRR using ERA-EDTA (European Renal Association-European Dialysis and Transplant Association) codes\u003Csup\u003E\u003Ca id=\u0022xref-ref-15-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-15\u0022\u003E15\u003C\/a\u003E\u003C\/sup\u003E and in UK renal IT systems either using PRD codes or free text. PRD codes and a list of search terms specific to each RaDaR RDG were decided with agreement from RDG leads (clinicians with expertise in that rare kidney disease), to generate an overall list of PRD codes and keywords for RaDaR diagnoses (Supplementary Table 4).\u003C\/p\u003E\u003Cp id=\u0022p-39\u0022\u003ETo assess whether there has been ethnic or socioeconomic status (SES) recruitment bias to RaDaR, three methods were used: 1) Ethnicity and SES of all prevalent RaDaR patients who had reached KF were compared with patients with a rare kidney diagnosis in the UKRR 2) Patients recruited to RaDaR from two large UK renal centres were compared with all unrecruited patients with a RaDaR eligible diagnosis at those centres 3) the age-stratified ethnicity distribution of England according to the 2011 UK census was compared with the ethnicity of prevalent English RaDaR patients with ADPKD. Patients from Scotland, Wales and Northern Ireland were excluded from all comparisons with the 2011 UK census due to lack of available data regarding age-stratified ethnicity from the ONS for those nations. English nationality was determined by a home address with an English postcode. More detailed information about these comparisons is presented in the Supplementary Methods.\u003C\/p\u003E\u003Cp id=\u0022p-40\u0022\u003EThe RaDaR database has approval for research studies from the NHS South-West-Central Bristol Research Ethics Committee (19\/SW\/0173). The report was written with reference to the Strengthening the Reporting of Observation Studies in Epidemiology (STROBE) statement\u003Csup\u003E\u003Ca id=\u0022xref-ref-16-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-16\u0022\u003E16\u003C\/a\u003E\u003C\/sup\u003E\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-14\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EResults\u003C\/h2\u003E\u003Cp id=\u0022p-41\u0022\u003EAs of July 2022, RaDaR recruits patients from 108 NHS sites (96 adult and 12 paediatric) across England (n=91), Scotland (n=9), Wales (n=3) and Northern Ireland (n=5). Most patients have been recruited from English renal units (n=23,776, 92%). Data from RDGs with \u226585 patients recruited are presented.\u003C\/p\u003E\u003Cdiv id=\u0022sec-15\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003EClinical demographics of the RaDaR Patient Population\u003C\/h3\u003E\u003Cp id=\u0022p-42\u0022\u003EClinical characteristics of 25,880 prevalent patients in RaDaR on 25\u003Csup\u003Eth\u003C\/sup\u003E July 2022 are displayed in \u003Ca id=\u0022xref-table-wrap-1-1\u0022 class=\u0022xref-table\u0022 href=\u0022#T1\u0022\u003ETable 1\u003C\/a\u003E. \u003Ca id=\u0022xref-table-wrap-2-1\u0022 class=\u0022xref-table\u0022 href=\u0022#T2\u0022\u003E2\u003C\/a\u003E,957 patients are now deceased. 125 patients (0.5%) have more than one diagnosis recorded; the majority of these are in the pregnancy RDG (115\/125, 92%).\u003C\/p\u003E\u003Cdiv id=\u0022T1\u0022 class=\u0022table pos-float\u0022\u003E\u003Cdiv class=\u0022table-inline table-callout-links\u0022\u003E\u003Cdiv class=\u0022callout\u0022\u003E\u003Cspan\u003EView this table:\u003C\/span\u003E\u003Cul class=\u0022callout-links\u0022\u003E\u003Cli class=\u0022view-inline first\u0022\u003E\u003Ca href=\u0022\u0022 class=\u0022table-expand-inline\u0022 data-table-url=\u0022\/highwire\/markup\/707120\/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0026amp;table-expand-inline=1\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView inline\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022view-popup\u0022\u003E\u003Ca href=\u0022\/highwire\/markup\/707120\/expansion?width=1000\u0026amp;height=500\u0026amp;iframe=true\u0026amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0022 class=\u0022colorbox colorbox-load table-expand-popup\u0022 rel=\u0022gallery-fragment-tables\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView popup\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022download-ppt last\u0022\u003E\u003Ca href=\u0022\/highwire\/powerpoint\/707120\u0022 class=\u0022highwire-figure-link highwire-figure-link-ppt\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload powerpoint\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022table-caption\u0022\u003E\u003Cspan class=\u0022table-label\u0022\u003ETable 1:\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EPatient demographics of individuals recruited to RaDaR, stratified by Rare Disease Group and current age*\u003C\/span\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022T2\u0022 class=\u0022table pos-float\u0022\u003E\u003Cdiv class=\u0022table-inline table-callout-links\u0022\u003E\u003Cdiv class=\u0022callout\u0022\u003E\u003Cspan\u003EView this table:\u003C\/span\u003E\u003Cul class=\u0022callout-links\u0022\u003E\u003Cli class=\u0022view-inline first\u0022\u003E\u003Ca href=\u0022\u0022 class=\u0022table-expand-inline\u0022 data-table-url=\u0022\/highwire\/markup\/707122\/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0026amp;table-expand-inline=1\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView inline\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022view-popup\u0022\u003E\u003Ca href=\u0022\/highwire\/markup\/707122\/expansion?width=1000\u0026amp;height=500\u0026amp;iframe=true\u0026amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0022 class=\u0022colorbox colorbox-load table-expand-popup\u0022 rel=\u0022gallery-fragment-tables\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView popup\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022download-ppt last\u0022\u003E\u003Ca href=\u0022\/highwire\/powerpoint\/707122\u0022 class=\u0022highwire-figure-link highwire-figure-link-ppt\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload powerpoint\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022table-caption\u0022\u003E\u003Cspan class=\u0022table-label\u0022\u003ETable 2:\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003EMinimum point prevalence rates and maximum area density estimates per 100,000 population*, stratified by RDG and sex\u003C\/span\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-43\u0022\u003EThe largest RDGs by patient number are ADPKD (n=7,112), Vasculitis (n=3,997), INS (n=3,917) and IgA nephropathy (n=3796). Conditions not presented due to low numbers are: Adenine phosphoribosyltransferase (APRT) deficiency (n=9), BK nephropathy (n=62), CKD due to Genetic factors in people of African Ancestry (CKD-AFRICA) (n=65), Calciphylaxis (n=59), Fabry Disease (n=47), Fibromuscular dysplasia (n=42), Mitochondrial renal disease (n=4) and Pure red cell aplasia (n=7).\u003C\/p\u003E\u003Cp id=\u0022p-44\u0022\u003EDistribution of rare kidney diseases differed between patients currently \u226418 years old (paediatric) and \u0026gt;18 years old (adults). Predominant rare kidney diseases in adults were ADPKD (n=6993, 29%), Vasculitis (16%; ANCA associated vasculitis n=1917, Anti-GBM disease n=115, Other Vasculitides n=1757) and IgA nephropathy (n= 3756, 16%). In children the largest RDGs were Idiopathic Nephrotic Syndrome (44%; SSNS\/MCD n= 525, SRNS\/FSGS n=256, INS-unspecified n= 63), Vasculitis (11%; ANCA associated vasculitis n=7, Anti-GBM disease \u22646, Other Vasculitides n=200) and Alport Syndrome (6%; X-linked Males n=53 X-linked Females n=46 TBMN n=16). The most common rare kidney diseases at time of diagnosis in adults and children were the same.\u003C\/p\u003E\u003Cp id=\u0022p-45\u0022\u003EMales were over-represented among paediatric patients with Cystinuria (68%), HNF1b mutations (61%), INS (60%) and Tubulopathies (71%) (due to male predominant Lowe Syndrome); among adult patients with Membranous Nephropathy (66%), Retroperitoneal Fibrosis (65%) and Primary Hyperoxaluria (66%); and among both children and adults with IgA nephropathy (children 63%, adults 70%). Minimum UK point prevalence and maximum area density estimates per 100,000 population for each RDG are presented in \u003Ca id=\u0022xref-table-wrap-2-2\u0022 class=\u0022xref-table\u0022 href=\u0022#T2\u0022\u003ETable 2\u003C\/a\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-46\u0022\u003EEthnic distribution and socioeconomic status for all RaDaR patients, stratified by RDG are presented in \u003Ca id=\u0022xref-fig-2-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F2\u0022\u003EFigure 2\u003C\/a\u003E. Excluding patients with missing data, 87% of RaDaR participants are White, 1% Mixed, 8% Asian, 3% Black and 1% Other ethnicities. For each RDG, the proportion of patients in each ethnic group was compared to the overall RaDaR proportion, excluding that RDG (Supplementary Figure 1). The SSNS\/MCD, SRNS\/FSGS, IgA nephropathy, Tubulopathies, Cystinosis and Primary Hyperoxaluria RDGs all had a significantly larger proportion of patients from Asian ethnic backgrounds than the total RaDaR population. This was particularly marked in the Cystinosis and Primary Hyperoxaluria RDGs where the proportion of patients from Asian backgrounds was higher than the overall RaDaR proportion by 17% (95% CI: 8%-25%) and 27% (95% CI: 17%-37%) respectively. Individuals recruited to the pregnancy RDG were also more likely to be from Asian or Black backgrounds, 8% (95% CI: 5%-12%) and 9% (95% CI: 6%-12%) increase respectively. Children recruited to RaDaR from all 4 UK nations were more likely to be from Asian ethnic backgrounds when compared to adults recruited to RaDaR (17% vs 8%, p\u0026lt;0.0001, Supplementary Table 5), and also when English children recruited to RaDaR were compared to children in the general English population (18% vs 10%, p-value \u0026lt;0.0001, Supplementary Table 6)\u003C\/p\u003E\u003Cdiv id=\u0022F2\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F2.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022RaDaR patient a) Ethnicity and b) Socioeconomic status, stratified by Rare Disease Gro\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-2128557798\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;RaDaR patient a) Ethnicity and b) Socioeconomic status, stratified by Rare Disease Gro\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 2:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F2.medium.gif\u0022 width=\u0022325\u0022 height=\u0022440\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 2:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F2.medium.gif\u0022 width=\u0022325\u0022 height=\u0022440\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F2.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 2:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F2.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 2:\u003C\/span\u003E \u003Cp id=\u0022p-47\u0022 class=\u0022first-child\u0022\u003ERaDaR patient a) Ethnicity and b) Socioeconomic status, stratified by Rare Disease Gro\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-48\u0022\u003E38% of patients recruited to RaDaR had monogenic disorders (disorders usually caused by inheritance of one or two pathogenic variants in a single gene, or a \u003Cem\u003Ede novo\u003C\/em\u003E mutation). Stratifying by ethnicity, White patients had the highest proportion of diagnosed monogenic disorders (38%) and Asian patients the lowest proportion (23%) (Supplementary Table 7). Adults recruited to RaDaR were more likely to be diagnosed with monogenic disorders than children (39% vs 30%, p-value \u0026lt;0.0001, Supplementary Table 8). Only adults from White, Mixed and Black backgrounds were more likely to be diagnosed with monogenic disorders compared to children; children from Asian or Other ethnic backgrounds are as likely to have a diagnosis of a monogenic disorder as adults (24% vs 23%, p-value 0.7 and 33% vs 32%, p-value 0.9 respectively).\u003C\/p\u003E\u003Cp id=\u0022p-49\u0022\u003ESocioeconomic deprivation varied by RDG; patients diagnosed with Cystinosis, Primary Hyperoxaluria, SSNS\/MCD, SRNS\/FSGS, IgA nephropathy, Membranous Nephropathy and Pregnancy were more likely to be in the most deprived IMD Quintile compared to the overall RaDaR population (Supplementary Figure 2). Individuals with non-monogenic disorders were more likely to be in the most deprived IMD Quintile compared to those with monogenic disorders, but this association was attenuated when stratifying by ethnicity (Supplementary Table 9). Individuals with autosomal dominant conditions were less likely to be in the most deprived quintile compared to those with autosomal recessive, X-linked or non-monogenic disorders (16% vs 20% vs 19% respectively, p-value \u0026lt;0.0001, Supplementary Table 10).\u003C\/p\u003E\u003Cp id=\u0022p-50\u0022\u003EMore paediatric patients were in the most deprived IMD Quintile when compared to adults recruited to RaDaR (30% vs 17%, Supplementary Table 5), and when compared to children in the general English population (Supplementary Table 6). Paediatric patients of White, Asian, and Other ethnicities were all more likely to be in the most deprived IMD quintile compared to adults (25% vs 16% p\u0026lt;0.0001, 54% vs 31% p\u0026lt;0.0001, 50% vs 25% p=0.02, respectively, Supplementary Table 11). Children with monogenic and non-monogenic disorders, and those with monogenic disorders with all modes of inheritance were more likely to be in the most deprived quintile compared to adults (Supplementary Tables 10 and 12).\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-16\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ERenal Function of the RaDaR patient population\u003C\/h3\u003E\u003Cp id=\u0022p-51\u0022\u003EMany patients in RaDaR had reached KF (CKD stage G5 or KRT) (39%) (\u003Ca id=\u0022xref-table-wrap-3-1\u0022 class=\u0022xref-table\u0022 href=\u0022#T3\u0022\u003ETable 3\u003C\/a\u003E). This proportion varied by RDG; only 2% of patients with Cystinuria had reached KF compared to 73% of male patients with AS, or 70% of patients with Cystinosis. Most paediatric patients had eGFR results \u0026gt;60ml\/ min\/1.73m\u003Csup\u003E\u003Ca id=\u0022xref-ref-2-2\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-2\u0022\u003E2\u003C\/a\u003E\u003C\/sup\u003E (71% CKD stages G1-G2 vs 32% adult patients).\u003C\/p\u003E\u003Cdiv id=\u0022T3\u0022 class=\u0022table pos-float\u0022\u003E\u003Cdiv class=\u0022table-inline table-callout-links\u0022\u003E\u003Cdiv class=\u0022callout\u0022\u003E\u003Cspan\u003EView this table:\u003C\/span\u003E\u003Cul class=\u0022callout-links\u0022\u003E\u003Cli class=\u0022view-inline first\u0022\u003E\u003Ca href=\u0022\u0022 class=\u0022table-expand-inline\u0022 data-table-url=\u0022\/highwire\/markup\/707119\/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0026amp;table-expand-inline=1\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView inline\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022view-popup\u0022\u003E\u003Ca href=\u0022\/highwire\/markup\/707119\/expansion?width=1000\u0026amp;height=500\u0026amp;iframe=true\u0026amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed\u0022 class=\u0022colorbox colorbox-load table-expand-popup\u0022 rel=\u0022gallery-fragment-tables\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EView popup\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022download-ppt last\u0022\u003E\u003Ca href=\u0022\/highwire\/powerpoint\/707119\u0022 class=\u0022highwire-figure-link highwire-figure-link-ppt\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload powerpoint\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022table-caption\u0022\u003E\u003Cspan class=\u0022table-label\u0022\u003ETable 3:\u003C\/span\u003E \u003Cspan class=\u0022caption-title\u0022\u003ECKD stage and Median eGFR of RaDaR patients on 1\u003Csup\u003Est\u003C\/sup\u003E January 2022\u003C\/span\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv id=\u0022sec-17\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ERecruitment to RaDaR\u003C\/h3\u003E\u003Cp id=\u0022p-52\u0022\u003EDistribution of recruitment to RaDaR across the UK is shown in \u003Ca id=\u0022xref-fig-3-1\u0022 class=\u0022xref-fig\u0022 href=\u0022#F3\u0022\u003EFigure 3\u003C\/a\u003E.\u003C\/p\u003E\u003Cdiv id=\u0022F3\u0022 class=\u0022fig pos-float type-figure  odd\u0022\u003E\u003Cdiv class=\u0022highwire-figure\u0022\u003E\u003Cdiv class=\u0022fig-inline-img-wrapper\u0022\u003E\u003Cdiv class=\u0022fig-inline-img\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F3.large.jpg?width=800\u0026amp;height=600\u0026amp;carousel=1\u0022 title=\u0022Distribution of recruitment to RaDaR across the United Kingdom\u0022 class=\u0022highwire-fragment fragment-images colorbox-load\u0022 rel=\u0022gallery-fragment-images-2128557798\u0022 data-figure-caption=\u0022\u0026lt;div class=\u0026quot;highwire-markup\u0026quot;\u0026gt;Distribution of recruitment to RaDaR across the United Kingdom\u0026lt;\/div\u0026gt;\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003E\u003Cspan class=\u0022hw-responsive-img\u0022\u003E\u003Cimg class=\u0022highwire-fragment fragment-image lazyload\u0022 alt=\u0022Figure 3:\u0022 src=\u0022data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\u0022 data-src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F3.medium.gif\u0022 width=\u0022440\u0022 height=\u0022336\u0022\/\u003E\u003Cnoscript\u003E\u003Cimg class=\u0022highwire-fragment fragment-image\u0022 alt=\u0022Figure 3:\u0022 src=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F3.medium.gif\u0022 width=\u0022440\u0022 height=\u0022336\u0022\/\u003E\u003C\/noscript\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cul class=\u0022highwire-figure-links inline\u0022\u003E\u003Cli class=\u0022download-fig first\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F3.large.jpg?download=true\u0022 class=\u0022highwire-figure-link highwire-figure-link-download\u0022 title=\u0022Download Figure 3:\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EDownload figure\u003C\/a\u003E\u003C\/li\u003E\u003Cli class=\u0022new-tab last\u0022\u003E\u003Ca href=\u0022https:\/\/www.medrxiv.org\/content\/medrxiv\/early\/2023\/09\/25\/2023.09.24.23296009\/F3.large.jpg\u0022 class=\u0022highwire-figure-link highwire-figure-link-newtab\u0022 target=\u0022_blank\u0022 data-icon-position=\u0022\u0022 data-hide-link-title=\u00220\u0022\u003EOpen in new tab\u003C\/a\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022fig-caption\u0022\u003E\u003Cspan class=\u0022fig-label\u0022\u003EFigure 3:\u003C\/span\u003E \u003Cp id=\u0022p-53\u0022 class=\u0022first-child\u0022\u003EDistribution of recruitment to RaDaR across the United Kingdom\u003C\/p\u003E\u003Cdiv class=\u0022sb-div caption-clear\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cp id=\u0022p-54\u0022\u003EOverall, patients recruited to RaDaR with KF were less likely to be Asian (7% vs 9%, p\u0026lt;0.0001) when compared with unrecruited patients in the UKRR dataset (Supplementary Table 13). However, there was no significant difference between the ethnic distribution of recruited vs. unrecruited patients in the following RDGs: ARPKD (Chi\u003Csup\u003E\u003Ca id=\u0022xref-ref-2-3\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-2\u0022\u003E2\u003C\/a\u003E\u003C\/sup\u003E p=0.41), AS (p=0.76), atypical HUS (p=0.55), Cystinosis (p=0.71), Primary Hyperoxaluria (p=0.49), MPGN\/C3GN (p=0.15), STEC-HUS (p=0.62), and Membranous Nephropathy (p=0.44). UKRR patients in the least deprived quintile were more likely to be recruited to RaDaR than those in the most deprived quintile (21% vs 17%, p\u0026lt;0.0001).\u003C\/p\u003E\u003Cp id=\u0022p-55\u0022\u003EResults comparing recruitment to RaDaR at two large renal centres were conflicting; comparing recruited and non-recruited patients at each centre, and excluding patients with ethnicity not recorded, there were no differences in ethnicity observed in one centre (p=0.23), and evidence of over-recruitment of White (67% vs 57%, p\u0026lt;0.0001) and under-recruitment of Black patients (8% vs 14%, p\u0026lt;0.0001) in the other centre. Similarly, there was no evidence of difference in social deprivation in one centre (p=0.67), whereas there was evidence of over-recruitment of patients in the least deprived quintile (19% vs 13%, p\u0026lt;0.0001) in the other.\u003C\/p\u003E\u003Cp id=\u0022p-56\u0022\u003EPrevalent English patients with a diagnosis of ADPKD were compared with the 2011 English Census, adjusted for age (Supplementary Figure 3). Deviation from the ethnic distribution of the English population varied by age-group. More patients aged \u0026lt;40 years were White than the general population (0-17 years 83% vs 79% p=0.006, 18-29 years 92% vs 81% p=0.001, 30-39 years 92% vs 81% p\u0026lt;0.0001). However, patients aged 60-69 years were more likely to be Black than the general population (3% vs 1%, p\u0026lt;0.0001). There was no difference in ethnic distribution for individuals more than 80 years old (p=0.39).\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section\u0022 id=\u0022sec-18\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EDiscussion\u003C\/h2\u003E\u003Cp id=\u0022p-57\u0022\u003EWe have presented cross-sectional analyses for 1,934 (7%) paediatric and 23,946 (93%) adult patients with rare kidney diseases enrolled into RaDaR. To our knowledge, this is the largest epidemiological description of rare kidney diseases worldwide.\u003C\/p\u003E\u003Cp id=\u0022p-58\u0022\u003ERaDaR is not a population-based registry, and therefore cannot offer precise incidence or prevalence data on individual rare kidney disorders; however, RaDaR patient numbers have allowed us to provide minimum point prevalence UK estimates for 21 RDGs, in some cases for the first time.Additionally, patient numbers and demographics may be useful in assessing feasibility of studies or clinical trials in individual rare kidney diseases.\u003C\/p\u003E\u003Cp id=\u0022p-59\u0022\u003EAfter comparison with multiple data sources, we found that while there was likely to be imperfect representation of all socio-economic and ethnic groups in RaDaR, the biases did not appear to be systematic or of a magnitude likely to distort inferences about epidemiology or natural history of RaDaR diseases. Whilst patients with KF in RaDaR are more likely to be White than eligible patients in the UKRR, comparison of the English RaDaR ADPKD cohort with the English census and comparison with patients two large renal units found no consistent ethnic recruitment bias to RaDaR. Patients recruited to RaDaR were more likely to be from the least deprived quintile compared to the UKRR, whereas there was no evidence of over-recruitment of patients in the least deprived quintile within a large renal unit, suggesting no systematic recruitment bias associated with social deprivation. Future work will include investigating these differences to identify potential inequity and to target future recruitment strategies. For seven RDGs (ARPKD, Alport syndrome, atypical HUS, STEC-HUS. cystinosis, primary hyperoxaluria, MPGN\/C3GN and membranous nephropathy) patients with KF recruited to RaDaR closely matched the ethnic distribution of patients in the UKRR.\u003C\/p\u003E\u003Cp id=\u0022p-60\u0022\u003EDespite evidence that patients of white ethnicities may be over-represented in the RaDaR KF population, we found patients with cystinosis and primary hyperoxaluria were less likely to be White, and more likely to be from Asian backgrounds compared to the overall ethnic distribution of RaDaR. This ethnic predisposition has been previously reported in cystinosis, with a high birth frequency rate (1:3,600) reported in Pakistani ethnic groups in the West Midlands\u003Csup\u003E\u003Ca id=\u0022xref-ref-17-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-17\u0022\u003E17\u003C\/a\u003E\u003C\/sup\u003E. However, to our knowledge it has not previously been reported in primary hyperoxaluria (PH). Previous population analyses have suggested PH is 3 times more prevalent amongst European Americans than African Americans\u003Csup\u003E\u003Ca id=\u0022xref-ref-18-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-18\u0022\u003E18\u003C\/a\u003E\u003C\/sup\u003E, and that certain PH1 gene mutations have a strong association with people from Spanish or North African backgrounds\u003Csup\u003E\u003Ca id=\u0022xref-ref-19-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-19\u0022\u003E19\u003C\/a\u003E\u003C\/sup\u003E. Whilst a possible mutational hotspot in PH3 gene \u003Cem\u003EHOGA1\u003C\/em\u003E has been identified in the Chinese population\u003Csup\u003E\u003Ca id=\u0022xref-ref-20-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-20\u0022\u003E20\u003C\/a\u003E\u003C\/sup\u003E, none of the patients in the RaDaR PH cohort were from a Chinese background. As autosomal recessive diseases, the frequency of consanguinity in the community may impact on the incidence of cystinosis and PH.\u003C\/p\u003E\u003Cp id=\u0022p-61\u0022\u003EPaediatric patients were more likely to be from Asian backgrounds compared to adults. This is likely due to the higher proportion of INS (SSNS, SRNS and INS-unspecified) in the paediatric group (44% children vs. 13% adults), conditions that have been reported to affect South Asians up to five times more frequently than Europeans\u003Csup\u003E\u003Ca id=\u0022xref-ref-21-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-21\u0022\u003E21\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-22-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-22\u0022\u003E22\u003C\/a\u003E\u003C\/sup\u003E.\u003C\/p\u003E\u003Cp id=\u0022p-62\u0022\u003EMore paediatric patients were in the lowest IMD quintile compared to adults. In the UK, children are more likely to live in more deprived areas compared to adults, and people of Asian and Black ethnicity are more likely to live in areas with the worst levels of social deprivation than those of White ethnicity\u003Csup\u003E\u003Ca id=\u0022xref-ref-23-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-23\u0022\u003E23\u003C\/a\u003E\u003C\/sup\u003E. However, the proportion of English children recruited to RaDaR living in the most deprived IMD quintile exceeded that of children in the general English population. Differences in ethnicity and the proportion of monogenic and non-monogenic conditions between the paediatric and adult RaDaR populations do not completely explain this disparity; children from White, Asian and other ethnicities were all more likely to live in more socially deprived areas than adults, as were children diagnosed with both monogenic and non-monogenic disorders. Paediatric patients may be more intensively recruited to RaDaR from centres in areas of worst deprivation, either due to clinician interest or a higher population prevalence of certain rare kidney diseases in those areas. Rare diseases are associated with a high economic burden for patients, especially for families with children\u003Csup\u003E\u003Ca id=\u0022xref-ref-24-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-24\u0022\u003E24\u003C\/a\u003E\u003C\/sup\u003E. Children from socioeconomically deprived backgrounds experience poorer health outcomes\u003Csup\u003E\u003Ca id=\u0022xref-ref-25-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-25\u0022\u003E25\u003C\/a\u003E,\u003Ca id=\u0022xref-ref-26-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-26\u0022\u003E26\u003C\/a\u003E\u003C\/sup\u003E, and there is evidence of reduced access to pre-emptive kidney transplantation in UK paediatric kidney patients from more deprived areas\u003Csup\u003E\u003Ca id=\u0022xref-ref-27-1\u0022 class=\u0022xref-bibr\u0022 href=\u0022#ref-27\u0022\u003E27\u003C\/a\u003E\u003C\/sup\u003E. These findings therefore highlight that children with rare kidney diseases recruited to RaDaR are a potentially highly vulnerable group; further investigation is needed to determine whether they experience differential outcomes.\u003C\/p\u003E\u003Cdiv id=\u0022sec-19\u0022 class=\u0022subsection\u0022\u003E\u003Ch3\u003ELimitations\u003C\/h3\u003E\u003Cp id=\u0022p-63\u0022\u003ERaDaR is a UK registry and is representative of the mainly White UK population and may not be generalisable to other ethnicities. Survivor bias may have had an impact on the enrolment of individuals with diagnoses made before RaDaR started recruiting patients with that condition.\u003C\/p\u003E\u003Cp id=\u0022p-64\u0022\u003ESome RaDaR diagnoses are poorly captured by ERA-EDTA PRD codes, which limited comparison to UKRR data. Entry of rare disease diagnoses into renal IT systems is user dependent and may vary between renal units used for comparisons.\u003C\/p\u003E\u003Cp id=\u0022p-65\u0022\u003EAlthough bias could be introduced owing to the variation in recruitment between centres across the UK, and therefore by variation in their catchment population, we sought to minimise effects of this bias by comparing ethnicity and SES of each RDG to the overall RaDaR breakdown. Caution must still be exercised where clinicians with particular interest in a certain RDG recruit more intensively into that one RDG compared to others.\u003C\/p\u003E\u003Cp id=\u0022p-66\u0022\u003EIn summary, to our knowledge, RaDaR is the largest registry of rare kidney diseases worldwide and provides numerous opportunities to study rare kidney diseases, including identification of potential participants in clinical trials.\u003C\/p\u003E\u003C\/div\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section data-availability\u0022 id=\u0022sec-21\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EData Availability\u003C\/h2\u003E\u003Cp id=\u0022p-67\u0022\u003EThe minimal underlying dataset cannot be included as it contains confidential, potentially identifying and sensitive patient information. The UK Kidney Association(UKKA) is the controller of the data and restricts sharing of individual level data if there is no direct relationship between the UKKA and the recipient. The data underlying these results are available for researchers\nwho meet the criteria for access to confidential\ndata.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section fn-group\u0022 id=\u0022fn-group-1\u0022\u003E\u003Ch2\u003EFootnotes\u003C\/h2\u003E\u003Cul\u003E\u003Cli class=\u0022fn-supported-by\u0022 id=\u0022fn-1\u0022\u003E\u003Cp id=\u0022p-1\u0022\u003E\u003Cstrong\u003ESources of support:\u003C\/strong\u003E RaDaR has received support from The UK Medical Research Council, Kidney Research UK, Kidney Care UK and the Polycystic Kidney Disease Charity. This work was partly supported by Pfizer Inc.\u003C\/p\u003E\u003C\/li\u003E\u003C\/ul\u003E\u003C\/div\u003E\u003Cdiv class=\u0022section ref-list\u0022 id=\u0022ref-list-1\u0022\u003E\u003Ch2 class=\u0022\u0022\u003EReferences\u003C\/h2\u003E\u003Col class=\u0022cit-list\u0022\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-1-1\u0022 title=\u0022View reference 1 in text\u0022 id=\u0022ref-1\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.1\u0022 data-doi=\u002210.1016\/S0140-6736(14)60659-0\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EDevuyst\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EO\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EKnoers\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ENVAM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERemuzzi\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESchaefer\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EF.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ERare inherited kidney diseases: challenges, opportunities, and perspectives\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ELancet\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E383\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E1844\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E59\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DLancet%26rft.volume%253D383%26rft.spage%253D1844%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252814%252960659-0%26rft_id%253Dinfo%253Apmid%252F24856029%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1016\/S0140-6736(14)60659-0\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=24856029\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2023%2F09%2F25%2F2023.09.24.23296009.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-2-1\u0022 title=\u0022View reference 2 in text\u0022 id=\u0022ref-2\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.2\u0022 data-doi=\u002210.1001\/jama.2019.0290\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EThomas\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECaplan\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EThe Orphan Drug Act Revisited\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJAMA\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2019\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E321\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E833\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E4\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJAMA%26rft.volume%253D321%26rft.spage%253D833%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.2019.0290%26rft_id%253Dinfo%253Apmid%252F30768155%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1001\/jama.2019.0290\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=30768155\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2023%2F09%2F25%2F2023.09.24.23296009.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-3-1\u0022 title=\u0022View reference 3 in text\u0022 id=\u0022ref-3\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.3\u0022 data-doi=\u002210.1093\/ndt\/gft315\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EW\u00fchl\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EVan Stralen\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EKJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWanner\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ERenal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA\u2013EDTA Registry\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENephrol Dial Transplant\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E29\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E1\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E8\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNephrol%2BDial%2BTransplant%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fndt%252Fgft315%26rft_id%253Dinfo%253Apmid%252F24145460%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1093\/ndt\/gft315\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=24145460\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2023%2F09%2F25%2F2023.09.24.23296009.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-4-1\u0022 title=\u0022View reference 4 in text\u0022 id=\u0022ref-4\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2023.09.24.23296009v1.4\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-source\u0022\u003E24th Annual Report - data to 31\/12\/2020 | The UK Kidney Association\u003C\/span\u003E. \u003Ca href=\u0022https:\/\/ukkidney.org\/audit-research\/annual-report\/24th-annual-report-data-31122020\u0022\u003Ehttps:\/\/ukkidney.org\/audit-research\/annual-report\/24th-annual-report-data-31122020\u003C\/a\u003E (accessed \u003Cspan class=\u0022cit-date-in-citation\u0022\u003EMay 22, 2023\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-5-1\u0022 title=\u0022View reference 5 in text\u0022 id=\u0022ref-5\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.5\u0022 data-doi=\u002210.1186\/S13023-021-01872-8\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBassanese\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EWlodkowski\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EServais\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EThe European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EOrphanet J Rare Dis\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E16\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003EDOI:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.1186\/S13023-021-01872-8\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DOrphanet%2BJ%2BRare%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1186%252FS13023-021-01872-8%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1186\/S13023-021-01872-8\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-6-1\u0022 title=\u0022View reference 6 in text\u0022 id=\u0022ref-6\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.6\u0022 data-doi=\u002210.1056\/NEJMoa2021436\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth cit-collab\u0022\u003EDexamethasone in Hospitalized Patients with Covid-19\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENew England Journal of Medicine\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E384\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E693\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E704\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.volume%253D384%26rft.spage%253D693%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa2021436%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1056\/NEJMoa2021436\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=http:\/\/www.n\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2023%2F09%2F25%2F2023.09.24.23296009.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-7-1\u0022 title=\u0022View reference 7 in text\u0022 id=\u0022ref-7\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2023.09.24.23296009v1.7\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-source\u0022\u003EEthnic group, national identity and religion - Office for National Statistics\u003C\/span\u003E. \u003Ca href=\u0022https:\/\/www.ons.gov.uk\/methodology\/classificationsandstandards\/measuringequality\/ethnicgroupnationalidentityandreligion\u0022\u003Ehttps:\/\/www.ons.gov.uk\/methodology\/classificationsandstandards\/measuringequality\/ethnicgroupnationalidentityandreligion\u003C\/a\u003E (accessed \u003Cspan class=\u0022cit-date-in-citation\u0022\u003EDec 30, 2022\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-8-1\u0022 title=\u0022View reference 8 in text\u0022 id=\u0022ref-8\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2023.09.24.23296009v1.8\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-source\u0022\u003EEnglish indices of deprivation 2019 - GOV.UK\u003C\/span\u003E. \u003Ca href=\u0022https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2019\u0022\u003Ehttps:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2019\u003C\/a\u003E (accessed \u003Cspan class=\u0022cit-date-in-citation\u0022\u003EDec 30, 2022\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-9-1\u0022 title=\u0022View reference 9 in text\u0022 id=\u0022ref-9\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2023.09.24.23296009v1.9\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-source\u0022\u003EWelsh Index of Multiple Deprivation | GOV.WALES\u003C\/span\u003E. \u003Ca href=\u0022https:\/\/www.gov.wales\/welsh-index-multiple-deprivation\u0022\u003Ehttps:\/\/www.gov.wales\/welsh-index-multiple-deprivation\u003C\/a\u003E (accessed \u003Cspan class=\u0022cit-date-in-citation\u0022\u003EDec 30, 2022\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-10-1\u0022 title=\u0022View reference 10 in text\u0022 id=\u0022ref-10\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2023.09.24.23296009v1.10\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-source\u0022\u003EScottish Index of Multiple Deprivation 2020 - gov.scot\u003C\/span\u003E. \u003Ca href=\u0022https:\/\/www.gov.scot\/collections\/scottish-index-of-multiple-deprivation-2020\/\u0022\u003Ehttps:\/\/www.gov.scot\/collections\/scottish-index-of-multiple-deprivation-2020\/\u003C\/a\u003E (accessed \u003Cspan class=\u0022cit-date-in-citation\u0022\u003EDec 30, 2022\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-11-1\u0022 title=\u0022View reference 11 in text\u0022 id=\u0022ref-11\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2023.09.24.23296009v1.11\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-source\u0022\u003ENorthern Ireland Multiple Deprivation Measure 2017 (NIMDM2017) | Northern Ireland Statistics and Research Agency\u003C\/span\u003E. \u003Ca href=\u0022https:\/\/www.nisra.gov.uk\/statistics\/deprivation\/northern-ireland-multiple-deprivation-measure-2017-nimdm2017\u0022\u003Ehttps:\/\/www.nisra.gov.uk\/statistics\/deprivation\/northern-ireland-multiple-deprivation-measure-2017-nimdm2017\u003C\/a\u003E (accessed \u003Cspan class=\u0022cit-date-in-citation\u0022\u003EDec 30, 2022\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-12-1\u0022 title=\u0022View reference 12 in text\u0022 id=\u0022ref-12\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.12\u0022 data-doi=\u002210.7326\/0003-4819-150-9-200905050-00006\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ELevey\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAS\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EStevens\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ELA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESchmid\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ECH\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EA New Equation to Estimate Glomerular Filtration Rate\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAnn Intern Med\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2009\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E150\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E604\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DAnnals%2Bof%2BInternal%2BMedicine%26rft.stitle%253DANN%2BINTERN%2BMED%26rft.aulast%253DLevey%26rft.auinit1%253DA.%2BS.%26rft.volume%253D150%26rft.issue%253D9%26rft.spage%253D604%26rft.epage%253D612%26rft.atitle%253DA%2BNew%2BEquation%2Bto%2BEstimate%2BGlomerular%2BFiltration%2BRate%26rft_id%253Dinfo%253Adoi%252F10.7326%252F0003-4819-150-9-200905050-00006%26rft_id%253Dinfo%253Apmid%252F19414839%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.7326\/0003-4819-150-9-200905050-00006\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=19414839\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2023%2F09%2F25%2F2023.09.24.23296009.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000265903800004\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-13-1\u0022 title=\u0022View reference 13 in text\u0022 id=\u0022ref-13\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2023.09.24.23296009v1.13\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-source\u0022\u003ESuppression rules - NHS Digital\u003C\/span\u003E. \u003Ca href=\u0022https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/data-quality\/data-quality-maturity-index-methodology\/suppression-rules\u0022\u003Ehttps:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/data-quality\/data-quality-maturity-index-methodology\/suppression-rules\u003C\/a\u003E (accessed \u003Cspan class=\u0022cit-date-in-citation\u0022\u003EFeb 12, 2023\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-14-1\u0022 title=\u0022View reference 14 in text\u0022 id=\u0022ref-14\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2023.09.24.23296009v1.14\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-source\u0022\u003EPopulation and household estimates, England and Wales - Office for National Statistics\u003C\/span\u003E. \u003Ca href=\u0022https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/bulletins\/populationandhouseholdestimatesenglandandwales\/census2021\u0022\u003Ehttps:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/bulletins\/populationandhouseholdestimatesenglandandwales\/census2021\u003C\/a\u003E (accessed \u003Cspan class=\u0022cit-date-in-citation\u0022\u003EAug 3, 2023\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-15-1\u0022 title=\u0022View reference 15 in text\u0022 id=\u0022ref-15\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.15\u0022 data-doi=\u002210.1093\/ndt\/gfs461\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EVenkat-Raman\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ETomson\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ECRV\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGao\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EY\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ENew primary renal diagnosis codes for the ERA-EDTA\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003ENephrology Dialysis Transplantation\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2012\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E27\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E4414\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DNephrology%2BDialysis%2BTransplantation%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fndt%252Fgfs461%26rft_id%253Dinfo%253Apmid%252F23175621%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1093\/ndt\/gfs461\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=23175621\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2023%2F09%2F25%2F2023.09.24.23296009.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000312645800029\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-16-1\u0022 title=\u0022View reference 16 in text\u0022 id=\u0022ref-16\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.16\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003Evon Elm\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EE\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAltman\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EDG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EEgger\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPocock\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ESJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EG\u00f8tzsche\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EPC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EVandenbroucke\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJP\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EThe Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EInternational Journal of Surgery\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2014\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E12\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E1495\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E9\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DInternational%2BJournal%2Bof%2BSurgery%26rft.volume%253D12%26rft.spage%253D1495%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-17-1\u0022 title=\u0022View reference 17 in text\u0022 id=\u0022ref-17\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.17\u0022 data-doi=\u002210.1136\/jmg.35.5.366\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHutchesson\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EACJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBundey\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ES\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPreece\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHall\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ESK\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGreen\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EA comparison of disease and gene frequencies of inborn errors of metabolism among different ethnic groups in the West Midlands, UK\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJ Med Genet\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E1998\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E35\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E366\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJournal%2Bof%2BMedical%2BGenetics%26rft.stitle%253DJ.%2BMed.%2BGenet.%26rft.aulast%253DHutchesson%26rft.auinit1%253DA%2BC%26rft.volume%253D35%26rft.issue%253D5%26rft.spage%253D366%26rft.epage%253D370%26rft.atitle%253DA%2Bcomparison%2Bof%2Bdisease%2Band%2Bgene%2Bfrequencies%2Bof%2Binborn%2Berrors%2Bof%2Bmetabolism%2Bamong%2Bdifferent%2Bethnic%2Bgroups%2Bin%2Bthe%2BWest%2BMidlands%252C%2BUK.%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fjmg.35.5.366%26rft_id%253Dinfo%253Apmid%252F9610798%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToiam1lZGdlbmV0IjtzOjU6InJlc2lkIjtzOjg6IjM1LzUvMzY2IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjMvMDkvMjUvMjAyMy4wOS4yNC4yMzI5NjAwOS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-18-1\u0022 title=\u0022View reference 18 in text\u0022 id=\u0022ref-18\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.18\u0022 data-doi=\u002210.1681\/ASN.2014070698\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EHopp\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EK\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECogal\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EAG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBergstralh\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EEJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EPhenotype-Genotype correlations and estimated carrier frequencies of primary hyperoxaluria\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EJournal of the American Society of Nephrology\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2015\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E26\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E2559\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E70\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bthe%2BAmerican%2BSociety%2Bof%2BNephrology%26rft_id%253Dinfo%253Adoi%252F10.1681%252FASN.2014070698%26rft_id%253Dinfo%253Apmid%252F25644115%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6ODoiam5lcGhyb2wiO3M6NToicmVzaWQiO3M6MTA6IjI2LzEwLzI1NTkiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMy8wOS8yNS8yMDIzLjA5LjI0LjIzMjk2MDA5LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-19-1\u0022 title=\u0022View reference 19 in text\u0022 id=\u0022ref-19\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.19\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECoulter-Mackie\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMB\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EPreliminary evidence for ethnic differences in primary hyperoxaluria type 1 genotype\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EAm J Nephrol\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2005\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E25\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E264\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E8\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DAmerican%2Bjournal%2Bof%2Bnephrology%26rft.stitle%253DAm%2BJ%2BNephrol%26rft.aulast%253DCoulter-Mackie%26rft.auinit1%253DM.%2BB.%26rft.volume%253D25%26rft.issue%253D3%26rft.spage%253D264%26rft.epage%253D268%26rft.atitle%253DPreliminary%2Bevidence%2Bfor%2Bethnic%2Bdifferences%2Bin%2Bprimary%2Bhyperoxaluria%2Btype%2B1%2Bgenotype.%26rft_id%253Dinfo%253Apmid%252F15961945%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=15961945\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2023%2F09%2F25%2F2023.09.24.23296009.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-20-1\u0022 title=\u0022View reference 20 in text\u0022 id=\u0022ref-20\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.20\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAbid\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA.\u003C\/span\u003E\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EPossible ethnic associations in primary hyperoxaluria type-III-associated HOGA1 sequence variants\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EMol Biol Rep\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E48\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E3841\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E4\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DMol%2BBiol%2BRep%26rft.volume%253D48%26rft.spage%253D3841%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-21-1\u0022 title=\u0022View reference 21 in text\u0022 id=\u0022ref-21\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.21\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EChanchlani\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ER\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EParekh\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ERS\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EEthnic Differences in Childhood Nephrotic Syndrome\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EFront Pediatr\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2016\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E4\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E39\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DFront%2BPediatr%26rft.volume%253D4%26rft.spage%253D39%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-22-1\u0022 title=\u0022View reference 22 in text\u0022 id=\u0022ref-22\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.22\u0022 data-doi=\u002210.1007\/s004670100021\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMcKinney\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EPA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EFeltbower\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ERG\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBrocklebank\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJT\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EFitzpatrick\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMM\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003ETime trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EPediatric Nephrology 2001 16:12\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2001\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E16\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E1040\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E4\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DPediatric%2Bnephrology%2B%2528Berlin%252C%2BGermany%2529%26rft.stitle%253DPediatr%2BNephrol%26rft.aulast%253DMcKinney%26rft.auinit1%253DP.%2BA.%26rft.volume%253D16%26rft.issue%253D12%26rft.spage%253D1040%26rft.epage%253D1044%26rft.atitle%253DTime%2Btrends%2Band%2Bethnic%2Bpatterns%2Bof%2Bchildhood%2Bnephrotic%2Bsyndrome%2Bin%2BYorkshire%252C%2BUK.%26rft_id%253Dinfo%253Adoi%252F10.1007%252Fs004670100021%26rft_id%253Dinfo%253Apmid%252F11793096%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.1007\/s004670100021\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=11793096\u0026amp;link_type=MED\u0026amp;atom=%2Fmedrxiv%2Fearly%2F2023%2F09%2F25%2F2023.09.24.23296009.atom\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-medline\u0022\u003E\u003Cspan\u003EPubMed\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=000173174300019\u0026amp;link_type=ISI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience\u0022\u003E\u003Cspan\u003EWeb of Science\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-23-1\u0022 title=\u0022View reference 23 in text\u0022 id=\u0022ref-23\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-web\u0022 id=\u0022cit-2023.09.24.23296009v1.23\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-source\u0022\u003EPeople living in deprived neighbourhoods - GOV.UK Ethnicity facts and figures\u003C\/span\u003E. \u003Ca href=\u0022https:\/\/www.ethnicity-facts-figures.service.gov.uk\/uk-population-by-ethnicity\/demographics\/people-living-in-deprived-neighbourhoods\/latest#full-page-history\u0022\u003Ehttps:\/\/www.ethnicity-facts-figures.service.gov.uk\/uk-population-by-ethnicity\/demographics\/people-living-in-deprived-neighbourhoods\/latest#full-page-history\u003C\/a\u003E (accessed \u003Cspan class=\u0022cit-date-in-citation\u0022\u003EJan 4, 2023\u003C\/span\u003E).\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-24-1\u0022 title=\u0022View reference 24 in text\u0022 id=\u0022ref-24\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.24\u0022 data-doi=\u002210.3390\/IJERPH191610366\/S1\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EGimenez-Lozano\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EP\u00e1ramo-Rodr\u00edguez\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EL\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECavero-Carbonell\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EC\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003ERare Diseases: Needs and Impact for Patients and Families: A Cross-Sectional Study in the Valencian Region, Spain\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EInt J Environ Res Public Health\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2022\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E19\u003C\/span\u003E.\u003Cspan class=\u0022cit-pub-id-sep cit-pub-id-doi-sep\u0022\u003E \u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id-scheme\u0022\u003EDOI:\u003C\/span\u003E\u003Cspan class=\u0022cit-pub-id cit-pub-id-doi\u0022\u003E10.3390\/IJERPH191610366\/S1\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DInt%2BJ%2BEnviron%2BRes%2BPublic%2BHealth%26rft_id%253Dinfo%253Adoi%252F10.3390%252FIJERPH191610366%252FS1%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/external-ref?access_num=10.3390\/IJERPH191610366\/S1\u0026amp;link_type=DOI\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref\u0022\u003E\u003Cspan\u003ECrossRef\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-25-1\u0022 title=\u0022View reference 25 in text\u0022 id=\u0022ref-25\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.25\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESpencer\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ENJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBlackburn\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ECM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ERead\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJM\u003C\/span\u003E\u003C\/span\u003E. \u003Cspan class=\u0022cit-article-title\u0022\u003EDisabling chronic conditions in childhood and socioeconomic disadvantage: a systematic review and meta-analyses of observational studies\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EBMJ Open\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2015\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E5\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E7062\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DBMJ%2BOpen%26rft.volume%253D5%26rft.spage%253D7062%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-26-1\u0022 title=\u0022View reference 26 in text\u0022 id=\u0022ref-26\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.26\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EMarmot\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EM\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EAllen\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EJ\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EBoyce\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ET\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EHEALTH EQUITY IN ENGLAND: THE MARMOT REVIEW 10 YEARS ON 2 Note from the Chair AUTHORS Report writing team: The Marmot Review team was led HEALTH FOUNDATION SOURCE MATERIALS FOR CASE STUDIES\u003C\/abbr\u003E. ; \u003Cspan class=\u0022cit-vol\u0022\u003E10\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003Cli\u003E\u003Ca class=\u0022rev-xref-ref\u0022 href=\u0022#xref-ref-27-1\u0022 title=\u0022View reference 27 in text\u0022 id=\u0022ref-27\u0022\u003E\u21b5\u003C\/a\u003E\u003Cdiv class=\u0022cit ref-cit ref-journal\u0022 id=\u0022cit-2023.09.24.23296009v1.27\u0022 data-doi=\u002210.2215\/CJN.11020720\u0022\u003E\u003Cdiv class=\u0022cit-metadata\u0022\u003E\u003Ccite\u003E\u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003EPlumb\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003ELA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ESinha\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EMD\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-auth\u0022\u003E\u003Cspan class=\u0022cit-name-surname\u0022\u003ECasula\u003C\/span\u003E  \u003Cspan class=\u0022cit-name-given-names\u0022\u003EA\u003C\/span\u003E\u003C\/span\u003E, \u003Cspan class=\u0022cit-etal\u0022\u003Eet al.\u003C\/span\u003E \u003Cspan class=\u0022cit-article-title\u0022\u003EAssociations between deprivation, geographic location, and access to pediatric kidney care in the United Kingdom\u003C\/span\u003E. \u003Cabbr class=\u0022cit-jnl-abbrev\u0022\u003EClinical Journal of the American Society of Nephrology\u003C\/abbr\u003E \u003Cspan class=\u0022cit-pub-date\u0022\u003E2021\u003C\/span\u003E; \u003Cspan class=\u0022cit-vol\u0022\u003E16\u003C\/span\u003E: \u003Cspan class=\u0022cit-fpage\u0022\u003E194\u003C\/span\u003E\u2013\u003Cspan class=\u0022cit-lpage\u0022\u003E203\u003C\/span\u003E.\u003C\/cite\u003E\u003C\/div\u003E\u003Cdiv class=\u0022cit-extra\u0022\u003E\u003Ca href=\u0022{openurl}?query=rft.jtitle%253DClinical%2BJournal%2Bof%2Bthe%2BAmerican%2BSociety%2Bof%2BNephrology%26rft_id%253Dinfo%253Adoi%252F10.2215%252FCJN.11020720%26rft_id%253Dinfo%253Apmid%252F33468533%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url\u0022\u003E\u003Cspan\u003EOpenUrl\u003C\/span\u003E\u003C\/a\u003E\u003Ca href=\u0022\/lookup\/ijlink\/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6ODoiY2xpbmphc24iO3M6NToicmVzaWQiO3M6ODoiMTYvMi8xOTQiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMy8wOS8yNS8yMDIzLjA5LjI0LjIzMjk2MDA5LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==\u0022 class=\u0022cit-ref-sprinkles cit-ref-sprinkles-ijlink\u0022\u003E\u003Cspan\u003E\u003Cspan class=\u0022cit-reflinks-abstract\u0022\u003EAbstract\u003C\/span\u003E\u003Cspan class=\u0022cit-sep cit-reflinks-variant-name-sep\u0022\u003E\/\u003C\/span\u003E\u003Cspan class=\u0022cit-reflinks-full-text\u0022\u003E\u003Cspan class=\u0022free-full-text\u0022\u003EFREE \u003C\/span\u003EFull Text\u003C\/span\u003E\u003C\/span\u003E\u003C\/a\u003E\u003C\/div\u003E\u003C\/div\u003E\u003C\/li\u003E\u003C\/ol\u003E\u003C\/div\u003E\u003Cspan class=\u0022highwire-journal-article-marker-end\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003Cspan class=\u0022related-urls\u0022\u003E\u003C\/span\u003E\u003C\/div\u003E\u003C\/div\u003E  \u003C\/div\u003E\n\n  \n  \u003C\/div\u003E\n\u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n\u003C\/div\u003E\u003Cscript type=\u0022text\/javascript\u0022 src=\u0022https:\/\/www.medrxiv.org\/sites\/default\/files\/js\/js_zP7WWIfzbyzvaM63L39cNV2juU_1XVH7wduFK9gcMNI.js\u0022\u003E\u003C\/script\u003E\n\u003C\/body\u003E\u003C\/html\u003E"}